Positive correlation of plasma transforming growth factor-β1 levels with tumor vascularity in hepatocellular carcinoma
- 1 February 1995
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 89 (1), 45-48
- https://doi.org/10.1016/0304-3835(95)90156-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseasesCancer, 1994
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.The Journal of cell biology, 1992
- Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1.The Journal of cell biology, 1992
- Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1992
- Modulation of c‐myc Expression by Transforming Growth Factor β1 in Human Hepatoma Cell LinesJapanese Journal of Cancer Research, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Transforming growth factor beta1 modulates extracellular matrix organization and cell‐cell junctional complex formation during in vitro angiogenesisJournal of Cellular Physiology, 1990
- Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix.The Journal of cell biology, 1988
- ANGIOGRAPHY OF PRIMARY LIVER CANCERAmerican Journal of Roentgenology, 1971